Motion Armour- Pillar Performance

MOTION ARMOUR Joint Longevity is a first-to-market combination of patented ingredients NEM®, 5-LOXIN® along with curcumin to provide an extensive natural joint protection formulation. Developed specifically to maintain joint cartilage health and support joint mobility/flexibility in highly active people, while also relieving mild joint inflammation, pain and stiffness.

NEM® is the patented egg shell membrane ingredient from Stratum Nutrition. NEM® is the world’s most clinically trialled egg shell membrane product and has clinical studies showing positive result to help support joints against pain, stiffness and inflexibility.

5-LOXIN® is a patented, clinically-studied boswellia extract with clinical trials showing positive benefit specifically for cartilage break-down. Every batch of the 5-LOXIN® harvest is traceable to a specific region and set of trees. 5-LOXIN® is strictly tested and must comply with predefined specifications at different stages of product manufacturing.

Key Features

• Formulated using patented natural ingredients.
• Maintains healthy joint cartilage.
• Relieves mild joint inflammation.
• Relieves mild joint pain and stiffness.
• Maintains joint mobility/flexibility.
• 60 film-coated tablets.

What are glycosaminoglycans and how do they help performance?

Glycosaminoglycans (or GAGs for short) are simply an umbrella category for a range of familiar compounds including collagen, hyaluronic acid, heparin and chondroitin. The serve a wide variety of biological functions, but most notably, serve as a key foundational player to musculoskeletal health – playing a pivotal role in the protection and maintenance of joints.

What is NEM® and 5-LOXIN®?

NEM® is a potent source of glycosaminoglycans, and is sustainably sourced from the delicate inner membrane found in used chicken eggshells, using organic materials that would otherwise be biological waste. 5-LOXIN® is a patented, clinically-studied boswellia extract. The principal bioactive compounds in Boswellia are boswellic acids, AKBA. Both have undergone significant clinical testing for their role in joint mobility and cartilage protection.